These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 31849448)

  • 1. Inhibition Of JNK Phosphorylation By Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury.
    Xiao Z; Xu F; Zhu X; Bai B; Guo L; Liang G; Shan X; Zhang Y; Zhao Y; Zhang B
    Drug Des Devel Ther; 2019; 13():4161-4171. PubMed ID: 31849448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
    Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
    Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetes.
    Liu Y; Wang Y; Miao X; Zhou S; Tan Y; Liang G; Zheng Y; Liu Q; Sun J; Cai L
    J Cell Mol Med; 2014 Jun; 18(6):1203-12. PubMed ID: 24720784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy.
    Pan Y; Wang Y; Zhao Y; Peng K; Li W; Wang Y; Zhang J; Zhou S; Liu Q; Li X; Cai L; Liang G
    Diabetes; 2014 Oct; 63(10):3497-511. PubMed ID: 24848068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of novel asymmetric C66 analogs as anti-inflammatory agents for the treatment of acute lung injury.
    Yu P; Dong L; Zhang Y; Chen W; Xu S; Wang Z; Shan X; Zhou J; Liu Z; Liang G
    Eur J Med Chem; 2015 Apr; 94():436-46. PubMed ID: 25828826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK Inhibitor SP600125 Attenuates Paraquat-Induced Acute Lung Injury: an In Vivo and In Vitro Study.
    Shen H; Wu N; Wang Y; Han X; Zheng Q; Cai X; Zhang H; Zhao M
    Inflammation; 2017 Aug; 40(4):1319-1330. PubMed ID: 28474156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach.
    Peritore AF; D'Amico R; Siracusa R; Cordaro M; Fusco R; Gugliandolo E; Genovese T; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Anti-Inflammatory Evaluation of Novel C66 Analogs for the Treatment of LPS-Induced Acute Lung Injury.
    Feng J; Xiao B; Chen W; Ding T; Chen L; Yu P; Xu F; Zhang H; Liu Z; Liang G
    Chem Biol Drug Des; 2015 Oct; 86(4):753-63. PubMed ID: 25727339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF1 meditates lipopolysaccharide-induced acute lung injury by up regulating JNK activation.
    Bin W; Ming X; Wen-Xia C
    Biochem Biophys Res Commun; 2019 Mar; 511(1):49-56. PubMed ID: 30760405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dachengqi decoction dispensing granule ameliorates LPS-induced acute lung injury by inhibiting PANoptosis in vivo and in vitro.
    Zhang M; Shang L; Zhou F; Li J; Wang S; Lin Q; Cai Y; Yang S
    J Ethnopharmacol; 2025 Jan; 336():118699. PubMed ID: 39181290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
    Wang Y; Zhou S; Sun W; McClung K; Pan Y; Liang G; Tan Y; Zhao Y; Liu Q; Sun J; Cai L
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1239-47. PubMed ID: 24714399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxymatrine attenuates lipopolysaccharide-induced acute lung injury by activating the epithelial sodium channel and suppressing the JNK signaling pathway.
    Jin B; Jin H
    Exp Anim; 2018 Jul; 67(3):337-347. PubMed ID: 29526865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway.
    Xu Y; Zhang R; Li C; Yin X; Lv C; Wang Y; Zhao W; Zhang X
    Fundam Clin Pharmacol; 2015 Oct; 29(5):462-71. PubMed ID: 26211495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
    Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
    Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin Attenuates Pulmonary Inflammation in Lipopolysaccharide Induced Acute Lung Injury in Neonatal Rat Model by Activating Peroxisome Proliferator-Activated Receptor γ (PPARγ) Pathway.
    Cheng K; Yang A; Hu X; Zhu D; Liu K
    Med Sci Monit; 2018 Feb; 24():1178-1184. PubMed ID: 29480285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIPE2 ameliorates lipopolysaccharide-induced apoptosis and inflammation in acute lung injury.
    Wu X; Kong Q; Zhan L; Qiu Z; Huang Q; Song X
    Inflamm Res; 2019 Nov; 68(11):981-992. PubMed ID: 31486847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor α‑induced protein 8‑like 2 contributes to penehyclidine hydrochloride pretreatment against lipopolysaccharide‑induced acute lung injury in a mouse model.
    Yuan M; Jing G; Kong Q; Ming T; Song X; Wu X
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice.
    Gao J; Teng L; Yang S; Huang S; Li L; Zhou L; Liu G; Tang H
    Biochem Pharmacol; 2021 Apr; 186():114499. PubMed ID: 33675774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabain Protects Mice Against Lipopolysaccharide-Induced Acute Lung Injury.
    Wang C; Meng Y; Wang Y; Jiang Z; Xu M; Bo L; Deng X
    Med Sci Monit; 2018 Jun; 24():4455-4464. PubMed ID: 29953424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2.
    Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G
    Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.